Community Health Systems, Inc. (CYH)

NYSE: CYH · USD

$2.65

-0.20 (-6.9%)· Recorded snapshot

Market cap	358.5M
Revenue (ttm)	12B
Net income (ttm)	252M
EPS (ttm)	$1.85
Shares out	135.5M
P/E (trailing)	1.4x
Volume	1,910,462
Beta	1.89

Market data

Price

Recent price action with selectable time range.

Financial snapshot

Revenue (ttm): 12B
Net income (ttm): 252M
EPS (ttm): $1.85
P/E (trailing): 1.4x
Market cap: 358.5M

Ticker	Name	Market cap	P/E	P/S	ROIC	5Y rev CAGR	1Y total return	Rating
EXAS	Exact Sciences Corp	—	—	—	—	—	—	Trzymaj

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector percentile context

Refreshed 2026-10-28 19:55 UTC

Forward P/En/a

P25 13.4P50 20.2P75 35.7

Trailing P/E1.4

P25 15.4P50 25.8P75 43.5

ROEn/a

P25 -113.8P50 -46.5P75 -0.9

ROIC8.2

P25 -68.5P50 -27.1P75 1.8

Benchmarks · 1M

All CYH indicators

Market & fundamental data

Available fields

247

Groups with data

Currency

USD

Showing 247 of 247 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Amount currency	USD
CIK code	0001108109
Company name	Community Health Systems, Inc.
Country	United States
Country code	US
CUSIP number	203668108
Earnings date	2026-10-28
Earnings time	amc
Employees	57,000
Employees change	-3,000
Employees growth	-5%
Enterprise value	$10.4B
Exchange	NYSE
Financial currency	USD
Financial report date	2026-06-30
First seen	2026-05-09
Fiscal year end	December
Founded	1985
In index	RUSSELL2000
Industry	Medical Care Facilities
IPO date	1991-03-07
Is primary listing	Yes
Is SPAC	No
ISIN number	US2036681086
Last 10-K release date	2026-02-19
Last earnings date	2026-10-28
Last refreshed	2026-10-28
Last stock split type	Never
Market cap	$358.5M
Market cap category	Small-Cap
Next earnings date	2027-02-17
Options	Yes
Price	$2.65
Price currency	USD
Sector	Healthcare
SIC code	8062
Stock price date	2026-10-28
Symbol	CYH
U.S. state	Tennessee
Website	https://www.chs.net

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Adjusted P/E ratio	4.41x
Earnings yield	70%
EV/Earnings	41.33x
EV/EBIT	10.88x
EV/EBITDA	7.82x
EV/Sales	0.87x
FCF / EV yield	-1.78%
FCF yield	-51.61%
Forward EV/Sales	0.92x
Forward P/S	0.03x
Industry forward P/E	15.38x
Industry P/E	18.76x
Lynch fair value	$9.26
Lynch upside	249.98%
P/(OCF - SBC) ratio	3.06x
P/E ratio	1.43x
P/OCF ratio	2.85x
P/S ratio	0.03x
Price/EBITDA ratio	0.27x
Sector forward P/E	23.56x
Sector P/E	50.08x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT margin	7.99%
EBITDA margin	11.12%
Effective tax rate	11.45%
Gross margin	41.41%
Operating margin	7.99%
Pretax margin	3.86%
Profit margin	2.1%
Profit per employee	$4,421
Profitable quarters	1
Profitable years	1
Revenue per employee	$210,228
ROA	4.63%
ROA (5Y)	4.1%
ROCE	9.42%
ROIC	8.16%
ROIC (5Y)	5.32%
SBC / revenue	0.08%
Tax / revenue	0.44%

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
EPS growth (Q)	-75.6%
EPS growth 3Y	-5.07%
EPS growth 5Y	-9.16%
EPS growth years	1
Gross profit growth	-6.22%
Gross profit growth (Q)	-11.22%
Gross profit growth 3Y	-0.09%
Gross profit growth 5Y	0.11%
Net income growth (Q)	-75.18%
Net income growth 3Y	-3.91%
Net income growth 5Y	-7.19%
Net income growth years	1
OCF growth	-74.34%
OCF growth 10Y	-19.1%
OCF growth 3Y	-18.99%
OCF growth 5Y	-29.97%
Operating income growth	8.75%
Operating income growth (Q)	-20.51%
Operating income growth 3Y	6.11%
Operating income growth 5Y	-3.37%
Revenue growth	-5.25%
Revenue growth (Q)	-9.83%
Revenue growth (QoQ)	-4.72%
Revenue growth 10Y	-4.62%
Revenue growth 3Y	-1.11%
Revenue growth 5Y	-0.46%
Revenue growth years	0

Financial statements

Income-statement and cash-flow amounts, totals and per share.

Metric	Value
Capital expenditures	$-311M
Depreciation and amortization	$375M
EBIT	$957M
EBITDA	$1.3B
EPS	$1.85
FCF per share	$-1.37
Financing cash flow	$-1.5B
Free cash flow	$-185M
Free cash flow minus SBC	$-194M
Gross profit	$5B
Income taxes	$53M
Investing cash flow	$1.1B
Net borrowing	$-1.3B
Net cash flow	$-307M
Net income	$252M
Operating cash flow minus SBC	$117M
Operating income	$957M
Revenue	$12B
Stock-based compensation	$9M

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Altman Z-Score	0.96
Book value per share	$-10.26
Debt / EBITDA	6.38
Goodwill	$3.2B
Interest coverage	1.11
Long-term assets	$9.1B
Long-term liabilities	$11B
Net cash (debt)	$-10.1B
Net cash / market cap	-2,805.26%
Net debt / EBITDA	7.55
Piotroski F-Score	5
Property, plant and equipment	$4.8B
Shareholders' equity	$-844M
Tangible book value	$-4.6B
Tangible book value per share	$-34.07
Total assets	$12.2B
Total cash	$149M
Total debt	$10.2B
Total liabilities	$13B
WACC	7.7%

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Asset turnover	0.93
Current assets	$3.1B
Current liabilities	$2B
Current ratio	1.53
Inventory turnover	23.52
Net working capital	$1B
Quick ratio	1.2
Working capital	$1.1B
Working capital turnover	9.87

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback yield / dilution	-2.26%
Dividend per share	$0.00
Dividend yield	0%
Last dividend	$0.25
Shareholder yield	-2.26%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
10Y price change	-47.52%
10Y return CAGR	-6.25%
10Y total return	-47.52%
150-day SMA	$2.97
15Y price change	-85.24%
15Y return CAGR	-10.81%
15Y total return	-82.02%
1D price change	-6.87%
1M price change	-9.86%
1M total return	-9.86%
1W price change	-7.02%
1W total return	-7.02%
1Y price change	-39.91%
1Y return CAGR	-39.93%
1Y total return	-39.91%
20-day SMA	$2.83
200-day SMA	$3.04
20Y price change	-91.89%
20Y return CAGR	-10.93%
20Y total return	-90.12%
3M price change	-2.57%
3M total return	-2.57%
3Y price change	26.79%
3Y return CAGR	8.23%
3Y total return	26.79%
50-day SMA	$2.89
50-day SMA vs 200-day SMA	50under200
52-week high	$4.42
52-week high date	2025-10-28
52-week low	$2.41
52-week low date	2026-04-24
5Y price change	-73.79%
5Y return CAGR	-23.5%
5Y total return	-73.79%
6M price change	-5.69%
6M total return	-5.69%
All-time high	$65.00
All-time high date	2015-06-29
All-time low	$1.79
All-time low date	2019-08-27
Average true range (ATR)	$0.13
Average volume	1.1M
Beta (1Y)	1.27
Beta (2Y)	1.66
Beta (5Y)	1.89
Change from 52-week high	-40.16%
Change from 52-week low	9.98%
Change from all-time high	-95.92%
Change from all-time low	48.04%
Change from open	-6.04%
Day's gap	-0.88%
Dollar volume	$5.1M
High price	$2.87
Low price	$2.64
Monthly RSI	44.24
Open price	$2.82
Position in 52-week range	2.17%
Premarket change	-0.7%
Premarket close	$2.84
Premarket price	$2.82
Premarket volume	483
Previous close	$2.84
Price vs 150-day SMA	-10.71%
Price vs 20-day SMA	-6.39%
Price vs 200-day SMA	-12.86%
Price vs 50-day SMA	-8.34%
Relative volume	1.68
RSI	37.69
Sharpe ratio	-0.85
Sharpe ratio (3Y)	0.29
Sharpe ratio (5Y)	-0.01
Sortino ratio	-1
Sortino ratio (3Y)	0.5
Sortino ratio (5Y)	0.05
Volume	1.9M
Weekly RSI	41.83
YTD price change	-15.06%
YTD total return	-15.06%

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	82.9M
Float percentage	61.2%
Shares change (QoQ)	1.55%
Shares change (YoY)	2.26%
Shares held by insiders	14.37%
Shares held by institutions	61.55%
Shares outstanding	135.5M
Short % of float	14.9%
Short % of shares	9.12%
Short ratio	10.3 days

Deeper analysis on CYH

14 sections in the full report · jump straight to what you need

Forecast

Base and Bull forecast paths with report-date return framing.

→

Valuation

Fair-value bridge, DCF, owner earnings, and peer multiples.

→

Sensitivity

Cost-of-equity and terminal-growth stress table.

→

Risks

Kill scenarios, soft-pass flags, and downside catalysts.

→

Earnings

Next earnings setup and beat / inline / miss thresholds.

→

Position sizing

Entry, exit, conviction, and quarterly monitoring rules.

→

Financials

Revenue, margins, cash flow, and balance-sheet context.

→

Peers

Relative valuation and profitability against the cohort.

→

Moat

Economic-profit evidence and competitive advantage risk.

→

Industry cycle

Sector phase, capital cycle, and secular tailwinds.

→

Frequently asked questions

About this CYH report

Is a complete CYH research report available?

No complete published report is available for Community Health Systems, Inc. (CYH) on this page. Market-directory data, when present, is not a substitute for a validated stock analysis.

Community Health Systems, Inc. (CYH)

Price

Financial snapshot

Fair-value bridge

Latest news · CYH

Valuation

Profitability

Balance sheet

Trading

Next earnings

Sector percentile context

All CYH indicators

Profile and market data

Valuation

Profitability

Growth

Financial statements

Financial strength

Liquidity

Dividends and buybacks

Performance and technicals

Ownership and float

Deeper analysis on CYH

Frequently asked questions